Your Questions About the New NICNAS Scheme Get Answered

As reported in May 2019 edition of this newsletter, there is now a new Australian industrial chemicals law – the Industrial Chemicals Act 2019. From 1 July 2020, NICNAS will be replaced by the Australian Industrial Chemicals Introduction Scheme (AICIS). This law also gives effect to the ban on the use of new animal test data for ingredients solely used in cosmetics. Please note that the ingredients in cosmetics are still regarded as industrial chemicals under the new scheme.     Source: AICIS Q&A

Delegate-only Decisions on Agricultural and Veterinary Chemicals may Affect Cosmetics

The latest version of the Poisons Standard (1 June 2019) indicates that the following two substances - N,N-dimethyloctanamide (CAS number 1118-92-9); and N,N-dimethyldecanamide (CAS number 14433-76-2), have gone from unscheduled to Schedule 6 Poisons, with no cut-off concentrations or exemptions from scheduling. This was a delegate-only decision that was not subject to a public consultation period. The substances were referred for scheduling by the APVMA, however the final decision applies to all uses of the substances, not just the AgVet use. Uses other than in AgVet products were identified as part of the scheduling consideration, including in coatings, industrial cleaning products, and processing aids. The European Chemicals Agency (ECHA) has also identified uses in polishes and waxes, washing & cleaning products including machine wash liquids/detergents, automotive care products, paints and coating or adhesives, fragrances and air fresheners. As such, manufacturers of cosmetic products may need to review their methods.   Source: Cosmetic ingredient rescheduling

ACCC Recalls Phytoplex Nourishing Skin Cream

The Australian Competition and Consumer Commission has recalled a cosmetic product supplied by Medline Two International Australia. Phytoplex Nourishing Skin Cream has been recalled due to the presence of certain species of mould, Penicillium chrysogenum and Penicillium flavigenum. The affected products are not likely to have any adverse effects in healthy individuals, but may pose a risk to people with weakened immune systems.    Source: Skin cream recall

Go to top